To Determine the Accuracy of SCreening for Occult REnal Disease (SCORED) Questionnaire for CKD Risk Among Asian Patients

AstraZeneca1,426 enrolled

Overview

To determine the accuracy of SCreening for Occult REnal Disease (SCORED) questionnaire for CKD risk among Asian Patients

Study Type

OBSERVATIONAL

Enrollment

1,426

Conditions

Chronic Kidney Disease

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: \- Exclusion Criteria: \-

Locations (3)

Perisai Husada

Bandung, West Java, Indonesia

Research Site

Surabaya, Indonesia

Nguyen Tri Phuong Hospital

Ho Chi Minh City, Vietnam

Outcomes

Primary Outcomes

Sensitivity and Specificity

The primary objective is to evaluate the accuracy of SCORED tool in identifying individuals at risk for the development of CKD in the Asian population. The primary outcomes, sensitivity, and specificity will be summarised using percentage and 95% confidence intervals to be measured at Baseline up to 6months after enrollment

Time frame: 28 February 2024

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.